Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
It is currently recognized that perpetual cross talk among key players in tumor microenvironment such as cancer cells (CCs), cancer associated fibroblasts (CAFs), and endothelial cells (ECs) plays a critical role in tumor progression, metastasis, and therapy resistance. Disruption of the cross talk may be useful to improve the outcome of therapeutics for which limited options are available. In the current study we investigate the use of gold nanoparticles (AuNPs) as a therapeutic tool to disrupt the multicellular cross talk within the TME cells with an emphasis on inhibiting angiogenesis. We demonstrate here that AuNPs disrupt signal transduction from TME cells (CCs, CAFs, and ECs) to ECs and inhibit angiogenic phenotypes in vitro. We show that conditioned media (CM) from ovarian CCs, CAFs, or ECs themselves induce tube formation and migration of ECs in vitro. Migration of ECs is also induced when ECs are cocultured with CCs, CAFs, or ECs. In contrast, CM from the cells treated with AuNPs or cocultured cells pretreated with AuNPs demonstrate diminished effects on ECs tube formation and migration. Mechanistically, AuNPs deplete ∼95% VEGF165 from VEGF single-protein solution and remove up to ∼45% of VEGF165 from CM, which is reflected on reduced activation of VEGF-Receptor 2 (VEGFR2) as compared to control CM. These results demonstrate that AuNPs inhibit angiogenesis via blockade of VEGF-VEGFR2 signaling from TME cells to endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, gold NPs block VEGF-VEGFR2 signaling from TME cells to endothelial cells and inhibit angiogenesis as reflected in reduced migration and tube formation of ECs when co-cultured with TCs in vitro [52].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Mechanisms and regulation of endothelial VEGF receptor signalling
Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498
The cell-cell adhesion molecule E-cadherin
van Roy, F., & Berx, G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8281-1 · Cited by 1,325
Targeting the tumour stroma to improve cancer therapy
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0007-1 · Cited by 1,084
Liu, Y., Cox, S. R., Morita, T., & Kourembanas, S. (1995) · Circulation Research · doi:10.1161/01.res.77.3.638 · Cited by 1,040
Identification, culture, and characterization of pancreatic stellate cells in rats and humans
Bachem, M. G., Schneider, E., Groß, H., Weidenbach, H., Schmid, R. M., Menke, A., Siech, M., Beger, H., Grünert, A., & Adler, G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70209-4 · Cited by 1,018
Biological properties of “naked” metal nanoparticles☆
BHATTACHARYA, R., & MUKHERJEE, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.013 · Cited by 917
Self-citationIn search of definitions: Cancer‐associated fibroblasts and their markers
Nurmik, M., Ullmann, P., Rodriguez, F., Haan, S., & Letellier, E. (2020) · International Journal of Cancer · doi:10.1002/ijc.32193 · Cited by 739
Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells
Namiki, A., Brogi, E., Kearney, M., Kim, E. A., Wu, T., Couffinhal, T., Varticovski, L., & Isner, J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31189 · Cited by 492
Antiangiogenic Properties of Gold Nanoparticles
Mukherjee, P., Bhattacharya, R., Wang, P., Wang, L., Basu, S., Nagy, J. A., Atala, A., Mukhopadhyay, D., & Soker, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2482 · Cited by 468
Self-citationMarti, H. H., & Risau, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15809 · Cited by 411
Jiang, Y., Huo, S., Mizuhara, T., Das, R., Lee, Y.-W., Hou, S., Moyano, D. F., Duncan, B., Liang, X.-J., & Rotello, V. M. (2015) · ACS Nano · doi:10.1021/acsnano.5b03521 · Cited by 401
Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy
Bertero, T., Oldham, W. M., Grasset, E. M., Bourget, I., Boulter, E., Pisano, S., Hofman, P., Bellvert, F., Meneguzzi, G., Bulavin, D. V., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.012 · Cited by 393
Albini, A., Bruno, A., Noonan, D. M., & Mortara, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00527 · Cited by 392
Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
Patra, C. R., Bhattacharya, R., Wang, E., Katarya, A., Lau, J. S., Dutta, S., Muders, M., Wang, S., Buhrow, S. A., Safgren, S. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6102 · Cited by 371
Self-citationCell Origins of High-Grade Serous Ovarian Cancer
Kim, J., Park, E., Kim, O., Schilder, J., Coffey, D., Cho, C.-H., & Bast, R. (2018) · Cancers · doi:10.3390/cancers10110433 · Cited by 264
Emerging understanding of the protein corona at the nano-bio interfaces
Mahmoudi, M., Bertrand, N., Zope, H., & Farokhzad, O. C. (2016) · Nano Today · doi:10.1016/j.nantod.2016.10.005 · Cited by 250
Zhang, Y., Tang, H., Cai, J., Zhang, T., Guo, J., Feng, D., & Wang, Z. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.011 · Cited by 242
Self-citationInhibition of tumor growth and metastasis by a self-therapeutic nanoparticle
Arvizo, R. R., Saha, S., Wang, E., Robertson, J. D., Bhattacharya, R., & Mukherjee, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214547110 · Cited by 237
Self-citationArvizo, R. R., Rana, S., Miranda, O. R., Bhattacharya, R., Rotello, V. M., & Mukherjee, P. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.01.011 · Cited by 229
Self-citationThibault, B., Castells, M., Delord, J.-P., & Couderc, B. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9456-2 · Cited by 184
Dual IRE 1 RN ase functions dictate glioblastoma development
Lhomond, S., Avril, T., Dejeans, N., Voutetakis, K., Doultsinos, D., McMahon, M., Pineau, R., Obacz, J., Papadodima, O., Jouan, F., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201707929 · Cited by 174
TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression
Gong, Y., Scott, E., Lu, R., Xu, Y., Oh, W. K., & Yu, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077366 · Cited by 166
The biomolecular corona of nanoparticles in circulating biological media
Pozzi, D., Caracciolo, G., Digiacomo, L., Colapicchioni, V., Palchetti, S., Capriotti, A. L., Cavaliere, C., Zenezini Chiozzi, R., Puglisi, A., & Laganà, A. (2015) · Nanoscale · doi:10.1039/c5nr03701h · Cited by 163
Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth
Saha, S., Xiong, X., Chakraborty, P. K., Shameer, K., Arvizo, R. R., Kudgus, R. A., Dwivedi, S. K. D., Hossen, M. N., Gillies, E. M., Robertson, J. D., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02231 · Cited by 163
Self-citationKim, J. H., Kim, M. H., Jo, D. H., Yu, Y. S., Lee, T. G., & Kim, J. H. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.030 · Cited by 157
PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway
Zhang, Y., & Daaka, Y. (2011) · Blood · doi:10.1182/blood-2011-04-350587 · Cited by 125
Self-citationGold nanoparticles in ophthalmology
Masse, F., Ouellette, M., Lamoureux, G., & Boisselier, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21509 · Cited by 125
Gold Nanoparticles Inhibit the Proliferation of Multiple Myeloma Cells
Bhattacharya, R., Patra, C. R., Verma, R., Kumar, S. K., Greipp, P. R., & Mukherjee, P. (2007) · Advanced Materials · doi:10.1002/adma.200602098 · Cited by 106
Self-citationChoi, H., & Moon, A. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1051-1 · Cited by 98
Li, W., Li, X., Liu, S., Yang, W., Pan, F., Yang, X.-Y., Du, B., Qin, L., & Pan, Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s128802 · Cited by 77
Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles
Xiong, X., Arvizo, R. R., Saha, S., Robertson, D. J., McMeekin, S., Bhattacharya, R., & Mukherjee, P. (2014) · Oncotarget · doi:10.18632/oncotarget.2203 · Cited by 73
Self-citationRonca, R., Van Ginderachter, J. A., & Turtoi, A. (2018) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000420 · Cited by 48
Roh, Y., Rho, C. R., Cho, W., & Kang, S. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19754 · Cited by 36
Tetraspanin-enriched microdomains regulate digitation junctions
Huang, C., Fu, C., Wren, J. D., Wang, X., Zhang, F., Zhang, Y. H., Connell, S. A., Chen, T., & Zhang, X. A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2803-2 · Cited by 35
Self-citationCellular localization and biological effects of 20nm‐gold nanoparticles
Tan, G., & Onur, M. A. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36373 · Cited by 31
Inhibition of retinal angiogenesis by gold nanoparticles via inducing autophagy
Shen, N., Zhang, R., Zhang, H.-R., Luo, H., Shen, W., Gao, X., Guo, D.-Z., & Shen, J. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.08.04 · Cited by 26
Protein corona variation in nanoparticles revisited: A dynamic grouping strategy
Rezaei, G., Daghighi, S. M., Haririan, I., Yousefi, I., Raoufi, M., Rezaee, F., & Dinarvand, R. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.003 · Cited by 22
Lo, H., Ma, M., Shieh, J., Chen, H., & Wu, W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s156880 · Cited by 18
Cannizzo, C. M., Adonopulos, A. A., Solly, E. L., Ridiandries, A., Vanags, L. Z., Mulangala, J., Yuen, S. C. G., Tsatralis, T., Henriquez, R., Robertson, S. E. J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700617r · Cited by 12
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“Thus, gold NPs block VEGF-VEGFR2 signaling from TME cells to endothelial cells and inhibit angiogenesis as reflected in reduced migration and tube formation of ECs when co-cultured with TCs in vitro [52] .”
BackgroundGold nanoparticles and gold nanorods in the landscape of cancer therapy
Kesharwani, P., Ma, R., Sang, L., Fatima, M., Sheikh, A., Abourehab, M. A. S., Gupta, N., Chen, Z.-S., & Zhou, Y. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01798-8 · Cited by 337
Hybrid Nanosystems for Biomedical Applications
Seaberg, J., Montazerian, H., Hossen, M. N., Bhattacharya, R., Khademhosseini, A., & Mukherjee, P. (2021) · ACS Nano · doi:10.1021/acsnano.0c09382 · Cited by 198
Self-citationFibroblasts in the Tumor Microenvironment
Truffi, M., Sorrentino, L., & Corsi, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_2 · Cited by 154
Tang, J., Meka, A. K., Theivendran, S., Wang, Y., Yang, Y., Song, H., Fu, J., Ban, W., Gu, Z., Lei, C., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202001469 · Cited by 135
Metadata
- Authors
- Zhang, Y., Xiong, X., Huai, Y., Dey, A., Hossen, M. N., Roy, R. V., Elechalawar, C. K., Rao, G., Bhattacharya, R., & Mukherjee, P.
- Affiliations
- University of Oklahoma Health Sciences Center (US)
- OU Health Stephenson Cancer Center (US)
- Corresponding author
- Mukherjee, Priyabrata
- ORCID
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-05-08
- Volume
- 30
- Issue
- 6
- Pages
- 1724-1733
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- PMC
- PMC6939887
- OpenAlex
- W2944502936
- Cited by
- 53
- References
- 48
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 9 · 2020: 8 · 2019: 3
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Bioconjugate Chemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA213278, 2CA136494, CA157481, 1R01 CA220237-01A1)
- National Heart, Lung, and Blood Institute (1R01HL120585)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Keywords
- gold nanoparticles, tumor microenvironment, angiogenesis inhibition, endothelial cells, cancer-associated fibroblasts, cancer cells, VEGF165, VEGFR2 signaling, tube formation, endothelial cell migration, conditioned medium, ovarian cancer
- MeSH terms
- Cell Movement, Female, Gold, Humans, Neovascularization, Pathologic, Ovarian Neoplasms, Tumor Cells, Cultured, Signal Transduction, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Endothelial Cells, Metal Nanoparticles, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.